Every material Form 8-K DXP Enterprises filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
DXP Enterprises reported third quarter 2026 results for the period ended September 30, 2026, with sales of $587.2 million, up 14.3% from a year earlier, and net income of $26.9 million, up 24.2%. Diluted earnings per share were $1.64 compared with $1.31 in the third quarter of 2025, and the company completed five acquisitions through the quarter.
Sales were $587.2 million versus $513.7 million in the third quarter of 2025; acquisitions contributed $48.8 million.
Net income was $26.9 million versus $21.6 million; diluted EPS was $1.64 versus $1.31.
Adjusted EBITDA was $67.3 million, up 19.0%, with an Adjusted EBITDA margin of 11.5% versus 11.0%.
Free cash flow was $14.4 million versus $28.1 million a year earlier; total debt was $839.5 million as of September 30, 2026.
DXP Enterprises' Board authorized a new program to repurchase up to $150.0 million or 1.0 million shares of common stock over the next 24 months, at management's discretion. The new program follows a previous $85.0 million or 2.5 million share program that concluded in August 2026, and the company may discontinue it at any time.
Up to $150.0 million or 1.0 million shares may be repurchased over the next 24 months
Previous program authorized up to $85.0 million or 2.5 million shares and concluded in August 2026
Approximately 16.4 million diluted weighted average shares outstanding as of June 30, 2026
Repurchases may occur in open market or privately negotiated transactions; no guarantee of exact amount
DXP Enterprises reported second quarter 2026 results for the period ended June 30, 2026. Sales rose 15.6% year over year to $576.5 million, and GAAP diluted EPS was $1.76, up from $1.43, while net income increased 21.6% to $28.7 million. The filing gives no financial guidance, and the company said it closed four acquisitions in the first half of 2026.
Sales of $576.5 million, up 15.6% from $498.7 million; acquisitions contributed $49.8 million
GAAP diluted EPS of $1.76 versus $1.43; Adjusted EBITDA of $70.4 million, up 22.8%
Free cash flow of $29.8 million versus $8.3 million a year earlier; total debt was $842.5 million at June 30, 2026
DXP Enterprises entered a Second Amended and Restated Loan Agreement on July 2, 2026, increasing commitments under its asset-based revolving credit facility by $40 million. The facility now totals $225 million and matures on July 2, 2031. The company says the change maintains liquidity, supports its acquisition strategy, and positions it to optimize its cost of capital.
Total ABL commitments rise from $185 million to $225 million, a $40 million increase.
Up to $210 million is available to US borrowers and up to $15 million to Canadian borrowers.
Interest accrues at Term SOFR or Term CORRA plus 1.25% to 1.75%, or at alternate base rates plus 0.25% to 0.75%, based on average daily excess availability.
The facility may be increased by up to $50 million in total, in minimum increments of $10 million, subject to conditions; Bank of America, N.A. is agent.
DXP Enterprises reported first quarter 2026 results for the period ended March 31, 2026. Sales rose 9.5% to $521.7 million, but net income fell to $20.0 million from $20.6 million and diluted EPS fell to $1.22 from $1.25, so headline profit measures declined while revenue grew.
Sales were $521.7 million, up from $476.6 million a year earlier, with Innovative Pumping Solutions up 37.7% to $118.7 million.
Net income was $20.0 million versus $20.6 million; diluted EPS was $1.22 versus $1.25 on 16.4 million diluted shares.
Adjusted EBITDA rose to $57.8 million from $52.5 million, and the company completed three acquisitions through the first quarter.
Total debt was $844.7 million at March 31, 2026, and cash was $213.4 million.
DXP Enterprises reported fourth-quarter and fiscal 2025 results on February 25, 2026. Sales and net income rose in both periods, with Q4 diluted EPS up to $1.39 from $1.29 and full-year diluted EPS up to $5.37 from $4.22. The filing gives no forward guidance, and the company said it raised an incremental $205 million under its Term Loan B during the fourth quarter.
Q4 2025 sales rose 12.0% to $527.4 million; Q4 net income rose 6.9% to $22.8 million
Q4 diluted EPS was $1.39 vs. $1.29 a year earlier; adjusted diluted EPS was $1.39 vs. $1.38
Fiscal 2025 sales rose 11.9% to $2.0 billion; net income rose 25.8% to $88.7 million
Refinancing raised an incremental $205 million and cut borrowing costs by 50 basis points; cash was $303.8 million at year end
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every DXP Enterprises filing is on SEC EDGAR ↗. 8-K briefs of other companies →